Skip to content

Clinical trials

Terminated Hematologic Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Terminated Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20121
20131
20142
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
Ariad Pharmaceuticals1
Hoffmann-La Roche1
Protalex, Inc.1
Seagen Inc.1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases7
Myeloproliferative Disorders5
Bone Marrow Diseases4
Polycythemia Vera4
Thrombocythemia, Essential3
Anemia2
Hemorrhagic Disorders2
Immunoproliferative Disorders2
Lymphatic Diseases2
Lymphoproliferative Disorders2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.